US-based firm VoCare has developed a cellular, medical diagnostic device Vitals360 for point-of-care use to measure six different health vitals and to remotely monitor patients.
The telehealth solution collects data on blood glucose, pulse, blood pressure, oximetry, temperature and electrocardiography (ecg), and is integrated with WiFi, Bluetooth, as well as 4G LTE to facilitate wireless data transmission.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Vitals360’s capability to provide multi vital measurements is expected to aid in the management of various chronic disorders such as diabetes, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and hypertension.
VoCare CEO Steven Peabody said: “We are looking forward to helping providers reduce healthcare costs as well as ensuring better outcomes for their exploding chronically ill patient population.”
The new diagnostic device employs an Android operating system backed by Qualcomm chipsets to enable its use with virtually all wireless carriers.
It is set to be introduced by software firm Harris Computer Systems’ GEMMS at the Healthcare Information and Management Systems (HIMMS) conference that will be held next month.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataGEMMS executive vice-president Rodger Pinto said: “The VoCare Vitals360 device along with GEMMS extensive experience in data management and interoperability will allow patient data to be captured easily from anywhere, at any time and sent in real time to providers.”
VoCare is currently working towards gaining the US Food and Drug Administration (FDA) clearance and the European CE-Mark for its Vitals360, and expects to commercialise the device in the US in the near future.
